Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of the Donor-specific and Complement-binding Anti-HLA Antibodies (C1q) Assays for the Management and the Monitoring After Liver Transplant

NCT03238443 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03238443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03238443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of the Donor-specific and Complement-binding Anti-HLA Antibodies (C1q) Assays for the Management and the Monitoring After Liver Transplant
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
February 16, 2016
Completion date
July 13, 2019
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant